| UniProt ID | 1A01_HUMAN | |
|---|---|---|
| UniProt AC | P30443 | |
| Protein Name | HLA class I histocompatibility antigen, A-1 alpha chain | |
| Gene Name | HLA-A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 365 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | Involved in the presentation of foreign antigens to the immune system.. | |
| Protein Sequence | MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQKMEPRAPWIEQEGPEYWDQETRNMKAHSQTDRANLGTLRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAQITKRKWEAVHAAEQRRVYLEGRCVDGLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWELSSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 336 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 336 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 337 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 337 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 343 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 343 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 344 | Y | Phosphorylation | Kinase | SRC | P12931 | GPS |
| 344 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
| 359 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
| 359 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 1A01_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
| 167 | Phosphorylation | 176 (9) | A ⇒ E;G;V | rs9256983 |
| 28928442 |
| 168 | Ubiquitination | 176 (8) | A ⇒ E;G;V | rs9256983 |
| 28928442 |
| 170 | Ubiquitination | 176 (6) | A ⇒ E;G;V | rs9256983 |
| 28928442 |
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| UGGG1_HUMAN | UGGT1 | physical | 17353931 | |
| CD8A_HUMAN | CD8A | physical | 9177355 | |
| CD8A_HUMAN | CD8A | physical | 10809759 | |
| COPB_HUMAN | COPB1 | physical | 11884415 | |
| COPG1_HUMAN | COPG1 | physical | 11884415 | |
| TPSN_HUMAN | TAPBP | physical | 11884415 | |
| TAP1_HUMAN | TAP1 | physical | 11884415 | |
| SYVN1_HUMAN | SYVN1 | physical | 21245296 | |
| UB2J1_HUMAN | UBE2J1 | physical | 21245296 | |
| DERL1_HUMAN | DERL1 | physical | 21245296 | |
| PSMD2_HUMAN | PSMD2 | physical | 21245296 | |
| MAGA4_HUMAN | MAGEA4 | physical | 21815906 | |
| BAP31_HUMAN | BCAP31 | physical | 17056546 | |
| B2MG_HUMAN | B2M | physical | 8805302 | |
| STAT3_HUMAN | STAT3 | physical | 21988832 | |
| GNAS3_HUMAN | GNAS | physical | 9914489 | |
| GNAS2_HUMAN | GNAS | physical | 9914489 | |
| ALEX_HUMAN | GNAS | physical | 9914489 | |
| GNAS1_HUMAN | GNAS | physical | 9914489 | |
| BAG6_HUMAN | BAG6 | physical | 21636303 | |
| MEOX2_HUMAN | MEOX2 | physical | 24722188 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00344 | Leprosy; Hansen disease | |||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-110, AND MASSSPECTROMETRY. | |